Real-time enrollment status for this adrenocortical cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT03583710 |
| Recruiting Status | Recruiting |
| Condition | Adrenocortical Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 3 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | January 30, 2026 (Jan 30, 2026) |
As of March 2, 2026: Clinical trial NCT03583710 is currently recruiting participants. This clinical trial study for adrenocortical cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03583710 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03583710 was last updated Jan 30, 2026 (January 30, 2026). HelloStudys verifies this status automatically.